Mini Mental State

Family caregivers of people with dementia, often called the invisible second patients, are critical to the quality of life of the care recipients. The effects of being a family caregiver, though sometimes positive, are generally negative, with high rates of burden and psychological morbidity as well as social isolation, physical ill-health, and financial hardship. Caregivers vulnerable to adverse effects can be identified, as can factors which ameliorate or exacerbate burden and strain. Psychosocial interventions have been demonstrated to reduce caregiver burden and depression and delay nursing home admission. Comprehensive management of the patient with dementia includes building a partnership between health professionals and family caregivers, referral to Alzheimer's Associations, and psychosocial interventions where indicated.

Family caregivers of people with dementia

The decline of cognitive function occurs with aging, but the mechanisms responsible are unknown. Astrocytes instruct the formation, maturation, and elimination of synapses, and impairment of these functions has been implicated in many diseases. These findings raise the question of whether astrocyte dysfunction could contribute to cognitive decline in aging. We used the Bac-Trap method to perform RNA sequencing of astrocytes from different brain regions across the lifespan of the mouse. We found that astrocytes have region-specific transcriptional identities that change with age in a region-dependent manner. We validated our findings using fluorescence in situ hybridization and quantitative PCR. Detailed analysis of the differentially expressed genes in aging revealed that aged astrocytes take on a reactive phenotype of neuroinflammatory A1-like reactive astrocytes. Hippocampal and striatal astrocytes up-regulated a greater number of reactive astrocyte genes compared with cortical astrocytes. Moreover, aged brains formed many more A1 reactive astrocytes in response to the neuroinflammation inducer lipopolysaccharide. We found that the aging-induced up-regulation of reactive astrocyte genes was significantly reduced in mice lacking the microglial-secreted cytokines (IL-1α, TNF, and C1q) known to induce A1 reactive astrocyte formation, indicating that microglia promote astrocyte activation in aging. Since A1 reactive astrocytes lose the ability to carry out their normal functions, produce complement components, and release a toxic factor which kills neurons and oligodendrocytes, the aging-induced up-regulation of reactive genes by astrocytes could contribute to the cognitive decline in vulnerable brain regions in normal aging and contribute to the greater vulnerability of the aged brain to injury.

https://www.pnas.org/content/pnas/115/8/E1896.full.pdf

Normal aging induces A1-like astrocyte reactivity

Today, frontotemporal dementia (FTD) remains one of the most common forms of early-onset dementia, that is, before the age of 65, thus posing several diagnostic challenges to clinicians since symptoms are often mistaken for psychiatric or neurological diseases causing a delay in correct diagnosis, and the majority of patients with FTD present with symptoms at ages between 50 and 60. Genetic components are established risk factors for FTD, but the influence of lifestyle, comorbidity, and environmental factors on the risk of FTD is still unclear. Approximately 40% of individuals with FTD have a family history of dementia but less than 10% have a clear autosomal dominant pattern of inheritance. Lack of insight is often an early clue to FTD. A tailored treatment option at an early phase can mitigate suffering and improve patients' and caregivers' quality of life.

Frontotemporal Dementia An Updated Clinician’s Guide

Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements.

Objective

We wanted to investigate the occurrence of depression in early onset dementia (EOD) patients and which characteristics were associated with depressive symptoms.



Methods

We included 221 patients who were diagnosed with dementia before the age of 65. Depression in these patients was measured by the Montgomery Asberg depression scale (MADRS). Measurements of cognition, behavioural and psychological symptoms and activities of daily life were along with hypothyroidism, diabetes and stroke included in the analysis. History of depression, current psychiatric co-morbidity and usage of antidepressants were recorded.



Results

Mean age of patients was 58.6 years (SD = 5.2); 50.6% were women. Of them 123 patients (55.6%) had a mild degree of depression (MADRS total score 7–19), 21 patients (9.5%) had a moderate degree of depression (MADRS total score 20–34) and only 1 patient had a severe degree of depression (MADRS total score ≥35). A factor analysis produced two factors; the first factor described dysphoria: lack of concentration, pessimistic thoughts, inner tension, suicidal thoughts lassitude and lack of sleep. The second factor denoted sadness: observed sadness, reported sadness, lack of appetite and inability to feel. In an adjusted linear regression analysis history of depression was the only significantly variable associated with the MADRS total score and both factors 1 and 2.



Conclusion

We found a high occurrence of depressive symptoms in EOD patients; 65.7% of all our patients had some degree of depression. A history of depression was the most important correlate of depression in these patients. Copyright © 2010 John Wiley & Sons, Ltd.

Occurrence of depression and its correlates in early onset dementia patients

Objective: To investigate the quality of life (QoL) and depression and its correlates in carers living with early onset dementia (EOD) patients. Method: The subjects were 49 carers, either married ...

Quality of life and depression in carers of patients with early onset dementia.

Objectives: To examine the provision of support to patients with frontotemporal dementia (FTD) and their family carers compared with patients with early onset Alzheimer's dementia (AD) and their carers, and the carers’ satisfaction with the support. Method: Data came from 60 dyads of patients with dementia and their principal family carers, 23 subjects with frontotemporal dementia and their 23 carers, and 37 subjects with early onset Alzheimer's disease and their 37 carers. Results: Patients with a frontotemporal dementia diagnosis were significantly more frequently offered stays in nursing homes (p = 0.04). Carers of patients with frontotemporal dementia were significantly less satisfied with the provision of information about the disease compared with carers of early onset Alzheimer's disease patients (p = 0.05) and were significantly less satisfied with counseling and follow-up advice (p = 0.05). Conclusion: Changes of personality in patients with frontotemporal dementia may be the major reason why the...

Support to family carers of patients with frontotemporal dementia

Objective To compare the time taken to establish a clinical diagnosis of Frontotemporal dementia (FTD) relative to a diagnosis of early onset Alzheimer's dementia (AD). Methods The data came from 89 patients under the age of 65 years, 52 of whom met the Manchester-Lund criteria for Frontotemporal dementia; 20 of these came from Lund University Hospital in Sweden. The other 32 patients with FTD along with 37 subjects who fulfilled the ICD-10 criteria for early onset Alzheimer's disease were recruited from four memory clinics and two neurology departments in Norway. Results For FTD patients in Norway it took 59.2 months (SD 36.1) from the onset of illness until a clinical FTD diagnosis was made. The corresponding time period for FTD patients in Sweden is 49.5 months (SD 24.5) and for AD patients in Norway 39.1 months (SD 19.9). The time from the first visit to a medical doctor until a diagnosis was made for the FTD patients in Norway was 34.5 months (SD 22.6), for the Swedish FTD patients 23.1 months (SD 22.4) and for the AD patients 25.9 months (SD 13.1). In all, 71% of FTD patients and 30% of AD patients initially received a non-dementia diagnosis. Conclusion More knowledge about early presenting cognitive and behavioural signs of FTD is needed in both primary and secondary health care to reduce the time period needed to establish a clinical diagnosis of FTD. Copyright (C) 2008 John Wiley & Sons, Ltd. (Less)

Tor Atle Rosness

Papers

Frontotemporal Dementia An Updated Clinician’s Guide

Occurrence of depression and its correlates in early onset dementia patients

Quality of life and depression in carers of patients with early onset dementia.

Support to family carers of patients with frontotemporal dementia

Frontotemporal dementia––a clinically complex diagnosis